Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation ( porine methotrexate or PUVA (psoralen ...)

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation

porine, methotrexate or PUVA (psoralen plus ultraviolet A light).

In February 2006, REMICADE was approved in the EU for the treatment of moderately-to-severely active UC in patients who have had an inadequate response to conventional therapy, including corticosteroids and 6-MP or azathioprine, or who are intolerant to or have medical contraindications for such therapies. This approval made REMICADE the first and only biologic therapy approved to treat moderate-to-severe UC in the EU. In May 2007, REMICADE was approved in the EU for the treatment of severe, active Crohn's disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy, or who are intolert to, or have contraindications for, such therapies.

REMICADE is the only anti-TNF biologic therapy available as an IV form. Unlike self-administered therapies that require patients to inject themselves frequently, REMICADE is the only anti-TNF biologic administered directly by caregivers in the clinic or office setting. In RA (3 mg/kg), CD (5 mg/kg), PsA (5 mg/kg), UC (5 mg/kg), PCD (5 mg/kg), and PsO (5 mg/kg), REMICADE is a two-hour infusion administered every 8 weeks, following a standard induction regimen that requires treatment at weeks 0, 2 and 6. As a result, REMICADE patients may require as few as six treatments each year. In AS (5 mg/kg), REMICADE is a two-hour infusion administered every 6 weeks, following a standard induction regimen that requires treatment at weeks 0, 2 and 6.

Centocor discovered REMICADE and has exclusive marketing rights to the product in the United States.

Schering-Plough markets REMICADE in all countries outside of the United States, except in Japan and parts of the Far East where Tanabe Seiyaku, Ltd. markets the product and in China where Xian-Janssen markets REMICADE.

Important Safety Information

There are reports of serious inf
'"/>

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
2. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
3. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
4. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
5. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
6. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
7. Inimex Product Candidate is First Immune Defense Regulator to Cure Infections Without Causing Harmful Inflammation

Post Your Comments:

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...

(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... sustained levels of drug reported after one treatmentLOUISVILLE, ... held biotechnology company developing medicines for the treatment ... it successfully completed its Phase I ASaP (Assessment ... with Neovascular Age-Related Macular Degeneration) clinical trial for ...

... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...

Other Medicine Technology:Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 2 Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 3 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3

Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II Ironwood Announces Linaclotide European Licensing Agreement with Almirall

(Date:12/15/2009)... have really been in trouble, expert says , , TUESDAY, ... pandemic H1N1 swine flu has revealed serious flaws in ... a new report says. , The report, prepared by ... Johnson Foundation, also finds the dire economy has strained ... H1N1 outbreak is the latest in a series of ...

(Date:12/15/2009)... delivered ,, WASHINGTON, Dec. 15 ... that healthcare reform does not override the prostate ... in 37 states. ,, Prostate cancer screening is ... and individuals who are identifiable as high risk, ... a family history of prostate cancer. The American ...

(Date:12/15/2009)... BERWYN, Pa., Dec. 15 4R Systems, ... supply chain solutions which help retailers significantly increase ... chain decisions, announced today that The Vitamin Shoppe ... 2008. ,, "4R,s store and DC inventory solutions ... inventory efficiency and in-stocks over the last two ...

(Date:12/15/2009)... NEW YORK, Dec. 15 The following are ... Attorney General for the criminal division, at the ... you, Secretary Sebelius. And thank you for the ... the HEAT initiative. ,, Together, our Departments ... lasting results. ,, We,ve made tremendous progress in ...

(Date:12/15/2009)... Continuing Strike Force Operations Lead to Indictment of ... with more than $61 Million in Fraudulent Billing ... Thirty people have been charged in ... to submit more than $61 million in false ... of the Medicare Fraud Strike Force, Department of ...

Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2 Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3 Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4 Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2 Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5

[0] Serious Gaps Revealed in U.S. Response to Health Emergencies [1] Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform [1] 4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance [1] Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference [1] Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La.

... follows ConAgra Foods Advisory on Pot Pies containing ... Stop & Shop,Supermarket Company LLC, following a product ... its shelves all ConAgra 7 oz. Banquet Pot,Pies ... the alert today., As a precautionary measure, ...

... Guttmacher,Institute,s latest report on world abortion rates is ... W. Mosher. The,study, just released today, argues that ... developing countries., Accurate numbers are impossible to ... illegal. Says Mosher: "Neither,Guttmacher nor anyone else knows ...

... they can potentially target chemotherapy for breast cancer to ... majority of patients from unnecessary side effects. , ... Cancer Center researchers, found women whose breast cancer expressed ... from adding the drug Taxol to the chemotherapy regimen, ...

... Oct. 10 Good Shepherd,Rehabilitation Network has ... Rehability. The virtual store at, http://www.rehabilitystores.com ... capability of secure online shopping specifically for ... aging, and their caregivers., "Rehability offers ...

... XYIENCE(R) Inc. (pronounced,zy-ince), one of the fastest growing ... that the company has received access,to up to $12 ... of,investors. The company intends to use a significant portion ... energy drink. The,name Xenergy is a combination of Zen ...

... leadership team; restructures business units ... ... announced the appointments of Paul D. Colvin as senior vice,president of ... of clinical operations for Asia. Mr. Colvin joins PPD from ...

Other Medicine News:Health News:Stop & Shop Alerts Customers to Product Advisory by ConAgra Foods 2 Health News:PRI Criticizes Guttmacher Report 2 Health News:HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds 2 Health News:HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds 3 Health News:Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products 2 Health News:XYIENCE(R) Announces $12 Million Funding and Signing of Long Term UFC(R) Sponsorship 2 Health News:PPD Names VPs for North America and Asia 2 Health News:PPD Names VPs for North America and Asia 3

Stop & Shop Alerts Customers to Product Advisory by ConAgra Foods PRI Criticizes Guttmacher Report HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products XYIENCE(R) Announces $12 Million Funding and Signing of Long Term UFC(R) Sponsorship PPD Names VPs for North America and Asia

Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat...

... Topical Anesthetic, ,Designed for adolescent ... incorporates an additional lumen and injection ... anesthetic above and below the cuff., ... designs which allow for CO2 monitoring, ...

Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....

SHERIDAN PREFORMED Endotracheal Tubes are designed to conveniently position the anesthesia circuit out of the surgical field for oral and maxillofacial procedures....

Medicine Products:

Left Carlens Carina Hook SHERIDAN LITA Cuffed Endotracheal Tube SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes SHERIDAN PREFORMED Oral Endotracheal Tubes

( porine methotrexate or PUVA (psoralen ...)Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation,Health